Overexpression of cathepsin B is associated with cancer and cathepsin B-sensitive peptides are widely used as cleavable linkers for the traceless release of therapeutic antibody–drug conjugates, e.g. DS-8201 and Adcetris. The gene discussed is CTSB; the disease is cancer.